These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6604586)

  • 21. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin.
    Wahl SM; Gately CL
    J Immunol; 1983 Mar; 130(3):1226-30. PubMed ID: 6218204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
    Brown TJ; Lioubin MN; Marquardt H
    J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.
    Drouet C; Reboul A; Colomb M
    Biochem J; 1989 Oct; 263(1):157-64. PubMed ID: 2481436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and partial characterization of human intracellular B cell growth factor.
    Sahasrabuddhe CG; Martin B; Maizel AL
    Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukemia cell maturation induced by a T-cell lymphokine isolated from medium conditioned by normal lymphocytes.
    Leung K; Chiao JW
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1209-13. PubMed ID: 3871947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
    Meshulam DH; Blair HE; Wong BL; Charm S; Minowada J; Rocklin RE
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):601-5. PubMed ID: 6952211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of excessive scleroderma fibroblast collagen production by lymphokines from normal human mononuclear cells.
    Jimenez SA; McArthur WM; Bashey RI; Rosenbloom J
    Arthritis Rheum; 1985 May; 28(5):502-10. PubMed ID: 4004960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): partial purification by antibody affinity chromatography and further characterization.
    Weisbart RH; Lusis AJ; Kacena A; Spolter L; Eggena P; Golde DW
    Clin Immunol Immunopathol; 1982 Mar; 22(3):408-18. PubMed ID: 7049465
    [No Abstract]   [Full Text] [Related]  

  • 31. A mutant human T-cell line producing immunosuppressive factor(s).
    Lau CY; Budz-Tymkewycz S; Wang EY; Ishaque A
    Cell Immunol; 1984 Aug; 87(1):35-52. PubMed ID: 6234996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An acidic lymphokine distinct from interferon-gamma inhibits the replication of herpes simplex virus in human pulmonary macrophages.
    Rose RM; Wasserman AS; Weiser WY; Remold HG
    Cell Immunol; 1986 Feb; 97(2):397-406. PubMed ID: 3017578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line.
    Goldstein H; Ambrus JL; Grove JH; Margolick JB; Fauci AS
    Cell Immunol; 1987 Sep; 108(2):343-55. PubMed ID: 2887297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity.
    Westbrook CA; Gasson JC; Gerber SE; Selsted ME; Golde DW
    J Biol Chem; 1984 Aug; 259(16):9992-6. PubMed ID: 6332112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes.
    Larsson EL; Mannervik B; Blomgren H
    Cell Immunol; 1979 May; 44(2):424-32. PubMed ID: 313270
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphokine (interleukin-2) production by mitogen-stimulated human lymphocytes in small reactors.
    Bödeker BG; Lehmann J; Mühlradt PF
    Dev Biol Stand; 1981; 50():193-200. PubMed ID: 6978826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV replication and lack of alteration of phytohemagglutinin-induced lymphokine production by peripheral blood mononuclear cells.
    Canque B; Rosenswajg M; Gluckman JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):204-6. PubMed ID: 7749799
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostaglandin E2 rather than lymphocyte-activating factor produced by activated human mononuclear cells stimulates increases in murine thymocyte cAMP.
    Oppenheim JJ; Koopman WJ; Wahl LM; Dougherty SF
    Cell Immunol; 1980 Jan; 49(1):64-73. PubMed ID: 6243256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.